US 8268776
Macrocylic oximyl hepatitis C protease inhibitors
granted A61PA61P31/12
Quick answer
US patent 8268776 (Macrocylic oximyl hepatitis C protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P31/12